Voici les articles que l’on a trouvé intéressants dernièrement sur la prévention du délirium, la santé mentale des travailleurs de la santé, mode ventilatoire TCAV, dexmédétomidine & sevrage ventilatoire difficile, inotropes & choc cardiogénique & la COVID-19.
Recommandations de la communauté – Merci à vous pour les excellentes suggestions !
- Revue systématique des interventions pharmacologiques et non-pharmaco en prévention du délirium
- Burry LD. Pharmacological and non-pharmacological interventions to prevent delirium in critically ill patients: a systematic review and network meta-analysis. Intensive Care Med. 2021 Aug 11:1–18. Epub ahead of print. PMID: 34379152; PMCID: PMC8356549.
- Burry LD. Pharmacological and non-pharmacological interventions to prevent delirium in critically ill patients: a systematic review and network meta-analysis. Intensive Care Med. 2021 Aug 11:1–18. Epub ahead of print. PMID: 34379152; PMCID: PMC8356549.
- Intervention par le personnel infirmier pour prévenir le délirium
- Rood PJ; UNDERPIN-ICU study investigators. The Impact of Nursing Delirium Preventive Interventions in the Intensive Care Unit: A Multicenter Cluster Randomized Controlled Trial. Am J Respir Crit Care Med. 2021 Jun 25. Epub ahead of print. PMID: 34170798.
- Impact de la COVID-19 sur la santé mentale des travailleurs de la santé
- Wozniak H. Mental health outcomes of ICU and non-ICU healthcare workers during the COVID-19 outbreak: a cross-sectional study. Ann Intensive Care. 2021 Jul 10;11(1):106. PMID: 34245380; PMCID: PMC8271328.
- Rapport de cas de cholangiopathie induite par la kétamine chez un patient COVID-19 en ARDS
- de Tymowski C. Ketamine-induced cholangiopathy in ARDS patients. Intensive Care Med. 2021 Jul 27:1–2. Epub ahead of print. PMID: 34313797; PMCID: PMC8315088.
Avez-vous un article à nous suggérer ? Laissez nous savoir !
Revue de presse
- Alternative en mode ventilatoire : la ventilation Time Controlled Adaptive Ventilation TCAV
- Janssen M. Time controlled adaptive ventilation™ as conservative treatment of destroyed lung: an alternative to lung transplantation. BMC Pulm Med. 2021 May 22;21(1):176. PMID: 34022829; PMCID: PMC8140588.
- L’étude BaSICS comparant les solutés balancés aux solutés saline 0,9%
- Zampieri FG; BaSICS investigators and the BRICNet members. Effect of Intravenous Fluid Treatment With a Balanced Solution vs 0.9% Saline Solution on Mortality in Critically Ill Patients: The BaSICS Randomized Clinical Trial. JAMA. 2021 Aug 10:e2111684. Epub ahead of print. PMID: 34375394; PMCID: PMC8356144.
- Étude sur l’impact sur la mortalité en sepsis de l’utilisation d’un beta-bloqueur à ultra-courte action chez les patients en tachycardie
- Gottlieb M. Effect of Ultrashort-Acting Beta Blocker Administration on Mortality for Patients With Sepsis and Persistent Tachycardia Despite Initial Resuscitation. Ann Emerg Med. 2021 Sep;78(3):381-383. Epub 2021 Jun 23. PMID: 34172302.
- Utilisation de la dexmédétomidine et le sevrage ventilatoire difficiles
- Buckley MS. Dexmedetomidine for Facilitating Mechanical Ventilation Extubation in Difficult-to-Wean ICU Patients: Systematic Review and Meta-Analysis of Clinical Trials. J Intensive Care Med. 2021 Aug;36(8):925-936. Epub 2020 Jul 6. PMID: 32627672.
- Étude comparant la milrinone à la dobutamine en choc cardiogénique
- Mathew R. Milrinone as Compared with Dobutamine in the Treatment of Cardiogenic Shock. N Engl J Med. 2021 Aug 5;385(6):516-525. PMID: 34347952.
COVID-19
- L’anticoagulation et les patients COVID-19 – REMAP-CAP, ACTIV-4a, etATTACC
- Papier #1 chez les patients COVID-19 critiques
- Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 4:NEJMoa2103417. Epub ahead of print. PMID: 34351722; PMCID: PMC8362592.
- Papier #2 chez les patients COVID-19 non-critiques
- Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19. N Engl J Med. 2021 Aug 4:NEJMoa2105911. Epub ahead of print. PMID: 34351721; PMCID: PMC8362594.
- Papier #1 chez les patients COVID-19 critiques
- Pré-publication de l’étude COVID STEROID 2 comparant dexaméthasone 12mg vs 6 mg
- Munch MW. Dexamethasone 12 mg versus 6 mg for patients with COVID-19 and severe hypoxia: an international, randomized, blinded trial. doi: https://doi.org/10.1101/2021.07.22.21260755
- L’impact de la dexaméthasone et du tocilizumab sur la valeur clinique de la CRP et la procalcitonine
- Kooistra EJ. Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients. Crit Care. 2021 Aug 5;25(1):281. PMID: 34353339; PMCID: PMC8340482.
- Étude sur la pharmacocinétique de l’énoxaparine en COVID-19
- Zufferey PJ. Pharmacokinetics of enoxaparin in COVID-19 critically ill patients. Thromb Res. 2021 Sep;205:120-127. Epub 2021 Jul 21. PMID: 34311154; PMCID: PMC8294601.
- «Vieux» papier mais toujours pertinent démontrant l’efficacité des vaccins contre le variant Delta (B.1.617.2)
- Lopez Bernal J. Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant. N Engl J Med. 2021 Aug 12;385(7):585-594. doi: 10.1056/NEJMoa2108891. Epub 2021 Jul 21. PMID: 34289274; PMCID: PMC8314739.
Commentaires
Commentaires